Stacey Johnson
Stacey Johnson is the editor of Signals and a contributor. For 25 years, Stacey has been providing strategic communications counsel to government, corporate, technology and health organizations. She began her career at the CTV Television Network and then moved to Hill & Knowlton Canada where she advised clients in a variety of industries and sectors. Stacey is the Vice President, Communications and Marketing for CCRM, a leader in developing and commercializing regenerative medicine-based technologies and cell and gene therapies. She has a Master's degree in Public Relations. You can follow her on Twitter @msstaceyerin.
Posts by: Stacey
Right Turn: Announcing a new blog for the cell and gene therapy industry
There’s a new blog in town and it’s in direct competition to Signals. Or is it? In our information saturated world, there is a great deal of competition for your attention. In 2015, Netflix users had streamed 42.5 billion hours of video and its users collectively spent 140 hours a day watching content from a […]
Right Turn: Viewer discretion advised when regenerative medicine goes to the movies
Writers will know that inspiration can come from the strangest places. Earlier this week I came across a Twitter thread from “Dr Esther @EstOdek” who was amusingly upset (I think that’s an oxymoron) that she learned, too late for her PhD on starfish, that The Hulk’s dad investigated the genetic basis of regeneration in starfish. […]
Right Turn: PR, propaganda, science, storytelling and a soupçon of stem cells
Propaganda is everywhere these days. Even (especially?) at a conference for public relations professionals. La Generalista, aka Alicia Wanless, was the opening keynote speaker at the recent Canadian Public Relations Society’s (CPRS) “Evolving Expectations” annual conference, held this year in Edmonton, Alberta. Ms. Wanless, a researcher at King’s College London, is an expert on information […]